
Big Pharma Split Corp.
TSX:PRM.TO
11.2 (CAD) • At close July 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||
Net Income
| -1.778 | 1.24 | -0.078 | -0.567 | 0.33 | 2.059 | 1.589 | 2.621 | 0.792 | -1.01 | 3.164 | -0.584 | 2.246 | -0.142 | 0.695 | 0.162 | 0.081 |
Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -0.029 | 0.017 | 0.01 | -0 | 0.056 | 0.119 | -0.016 | -0.139 | 0.003 | -0.034 | 0.016 | -0.019 | 0.015 | -0.069 | -0.013 | 0.027 | 0.014 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -0.029 | 0.017 | 0.01 | -0 | 0.056 | 0.119 | -0.016 | -0.139 | 0.003 | -0.034 | 0.016 | -0.019 | 0.015 | -0.069 | 0 | 0 | 0 |
Other Non Cash Items
| 0.934 | 0.481 | -0.722 | 0.937 | -3.05 | -2.06 | -3.544 | -9.511 | 2.235 | 2.363 | 4.336 | 1.766 | -0.623 | -0.157 | -0.364 | -15.666 | -7.833 |
Operating Cash Flow
| -0.873 | 1.738 | -0.79 | 0.369 | -2.663 | 0.118 | -1.971 | -7.029 | 3.03 | 1.319 | 7.516 | 1.163 | 1.638 | -0.367 | 0.318 | -15.477 | -7.739 |
Investing Activities: | |||||||||||||||||
Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 2.351 | 0 | 0 | 0 | 0 | 0 | 0.664 | 0.664 | -0.75 | -0.375 | 0 | 0 |
Financing Activities: | |||||||||||||||||
Debt Repayment
| 0.546 | 0 | -0.132 | -5.354 | 0 | 0.562 | 3.404 | 8.089 | -2.468 | 0 | -5.654 | 0 | -0.382 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 0.343 | 0 | 0.445 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.2 | 5.1 |
Common Stock Repurchased
| -0.445 | -0.024 | -0.807 | -4.515 | 0 | 0 | 0 | 0 | -1.687 | 0 | -3.658 | -3.243 | -0.265 | -0 | -0.114 | 0 | 0 |
Dividends Paid
| -0.7 | -0.804 | -0.736 | -0.804 | -0.937 | -1.301 | -1.188 | -1.649 | -0.812 | -0.919 | -0.919 | -1.165 | -1.172 | -1.082 | -0.563 | 0 | 0 |
Other Financing Activities
| 0 | 0.738 | 0.488 | 4.935 | 0.379 | -0.121 | -3.455 | -7.976 | 2.921 | 0 | -0.39 | 0 | -0.016 | 0.004 | -0.114 | 10.2 | 5.1 |
Financing Cash Flow
| -0.256 | -0.091 | -1.229 | -10.673 | -0.737 | -0.622 | 2.781 | 7.412 | -3.733 | -0.919 | -7.405 | -1.165 | -1.624 | -1.086 | -0.677 | 10.2 | 5.1 |
Other Information: | |||||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | -0.002 | 0.001 | -0.004 | 0.007 | -0.002 | 0 | -0.002 | 0.009 | -0.659 | 0.01 | 0.755 | 0.378 | -0.256 | -0.128 |
Net Change In Cash
| 0 | 1.389 | -0.193 | -0.422 | -0.102 | 0.922 | 0.409 | 0.191 | -0.352 | 0.199 | 0.06 | 0.311 | 0.03 | -0.069 | -0.357 | -2.767 | -2.767 |
Cash At End Of Period
| 1.031 | 1.593 | 0.204 | 0.398 | 0.819 | 0.922 | 0.409 | 0.613 | -0.352 | 0.934 | 0.06 | 0.416 | 0.134 | 0.393 | 0.104 | 0.461 | 0.461 |